NCT06250348View on ClinicalTrials.gov

Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

January 5, 2025

Conditions
ARDS, HumanNitric Oxyde
Interventions
OTHER

Non invasive measure of endogenous exhaled Nitric Oxyde in exhaled gaz, by a laser spectrometer

A sample of exhaled gases is taken from the expiratory part of the respirator circuit (same way as a capnometry measurement). A laser spectrometer continuously and non-invasively monitors online the concentrations of endogenous NO exhaled by patients.

Trial Locations (1)

38000

CHU Grenoble Alpes, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06250348 - Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter